TARSUS PHARMACEUTICALS, INC. Depreciation
TARSUS PHARMACEUTICALS, INC. (TARS) reported Depreciation of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- TARSUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-06-30 was $800.00K, a 300.00% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-03-31 was $197.00K, a 10.45% decline year-over-year.
- TARSUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-12-31 was $202.00K, a 5.21% increase year-over-year.
- TARSUS PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- TARSUS PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $855.00K, a 24.82% increase from fiscal 2024.
- TARSUS PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $685.00K, a 7.93% decline from fiscal 2023.
- TARSUS PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $744.00K, a 128.22% increase from fiscal 2022.
- TARSUS PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $326.00K, a 8.67% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-08-06 | $957.00K 10-Q · filed 2026-08-06 | $1.20M derived: sum of 3 quarters · filed 2026-08-06 | $1.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $197.00K 10-Q · filed 2026-05-06 | $399.00K derived: sum of 2 quarters · filed 2026-05-06 | $599.00K derived: sum of 3 quarters · filed 2026-05-06 | $799.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $402.00K derived: sum of 2 quarters · filed 2026-02-23 | $602.00K derived: sum of 3 quarters · filed 2026-08-06 | $855.00K 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-04 | $400.00K derived: sum of 2 quarters · filed 2026-08-06 | $653.00K 10-Q · filed 2025-11-04 | $812.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-06 | $433.00K 10-Q · filed 2026-08-06 | $612.00K derived: sum of 3 quarters · filed 2026-08-06 | $812.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $220.00K 10-Q · filed 2026-05-06 | $412.00K derived: sum of 2 quarters · filed 2026-05-06 | $612.00K derived: sum of 3 quarters · filed 2026-05-06 | $712.00K derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $392.00K derived: sum of 2 quarters · filed 2026-02-23 | $492.00K derived: sum of 3 quarters · filed 2026-02-23 | $685.00K 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-04 | $300.00K derived: sum of 2 quarters · filed 2025-11-04 | $493.00K 10-Q · filed 2025-11-04 | $717.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-06 | $309.00K 10-Q · filed 2025-08-06 | $517.00K derived: sum of 3 quarters · filed 2026-02-23 | $717.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $170.00K 10-Q · filed 2025-05-01 | $417.00K derived: sum of 2 quarters · filed 2026-02-23 | $617.00K derived: sum of 3 quarters · filed 2026-02-23 | $817.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $447.00K derived: sum of 2 quarters · filed 2026-02-23 | $647.00K derived: sum of 3 quarters · filed 2026-02-23 | $744.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 2 quarters · filed 2024-11-13 | $497.00K 10-Q · filed 2024-11-13 | $603.00K derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-08 | $286.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2023-08-10 | $403.00K derived: sum of 3 quarters · filed 2025-02-25 | $503.00K derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | $104.00K 10-Q · filed 2024-05-08 | $100.00K 10-Q · filed 2023-05-09 | $203.00K derived: sum of 2 quarters · filed 2025-02-25 | $303.00K derived: sum of 3 quarters · filed 2025-02-25 | $403.00K derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $199.00K derived: sum of 2 quarters · filed 2025-02-25 | $299.00K derived: sum of 3 quarters · filed 2025-02-25 | $326.00K 10-K · filed 2025-02-25 | $300.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $227.00K 10-Q · filed 2023-11-09 | $200.00K 10-Q · filed 2022-11-09 | $300.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $92.00K 10-Q · filed 2022-08-11 | $100.00K 10-Q · filed 2023-08-10 | $133.00K 10-Q · filed 2022-08-11 | $200.00K derived: sum of 3 quarters · filed 2023-08-10 | $300.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-09 | $41.00K 10-Q · filed 2022-05-11 | $100.00K derived: sum of 2 quarters · filed 2023-05-09 | $200.00K derived: sum of 3 quarters · filed 2023-05-09 | $325.00K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $100.00K derived: sum of 2 quarters · filed 2023-03-17 | $225.00K derived: sum of 3 quarters · filed 2023-03-17 | $300.00K 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-09 | $225.00K derived: sum of 2 quarters · filed 2022-11-09 | $300.00K 10-Q · filed 2022-11-09 | $289.00K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $125.00K 10-Q · filed 2022-08-11 | $189.00K 10-Q · filed 2022-08-11 | $189.00K derived: sum of 3 quarters · filed 2022-08-11 | $213.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $64.00K 10-Q · filed 2022-05-11 | $64.00K derived: sum of 2 quarters · filed 2022-05-11 | $88.00K derived: sum of 3 quarters · filed 2022-05-11 | $105.00K derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $24.00K derived: sum of 2 quarters · filed 2022-03-14 | $41.00K derived: sum of 3 quarters · filed 2022-03-14 | $100.00K 10-K · filed 2022-03-14 | ||||
| 2020-09-30 | $24.00K 10-Q · filed 2021-11-10 | $41.00K derived: sum of 2 quarters · filed 2021-11-10 | $100.00K 10-Q · filed 2021-11-10 | $56.00K 10-Q · filed 2020-11-25 | $75.00K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $17.00K 10-Q · filed 2021-08-05 | $32.00K 10-Q · filed 2021-08-05 | $51.00K derived: sum of 3 quarters · filed 2021-08-05 | $60.00K derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-11 | $34.00K derived: sum of 2 quarters · filed 2021-05-11 | $43.00K derived: sum of 3 quarters · filed 2021-05-11 | |||||
| 2019-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $28.00K derived: sum of 2 quarters · filed 2021-03-31 | $37.00K 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $9.00K 10-Q · filed 2020-11-25 | $18.00K 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |